$42.16
Price
$1.3B
Market Cap
20.6
P/E Ratio
9.5
Forward P/E
$2.05
EPS (TTM)
1.90%
Dividend Yield
$39M
Cash
$906M
Total Debt
31M
Shares Out
$38.32
$74.70
52-Week Range
Institutional Ownership of CONMED CORP
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for CONMED CORP
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for CONMED CORP
6 Months Insider Sentiment
Buy $0
Sell $268K
0
Buys
4
Sells
-268K
Net
0
Grants
Largest
$150K
Garner
$59K
Farkas
$48K
Farkas
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 21, 2025 | Richard Glaze | Chief Information Officer | SELL | 257 | $41.21 | $11K |
| Nov 20, 2025 | Richard Glaze | Chief Information Officer | EXERCISE | 375 | — | — |
| Nov 06, 2025 | Todd W Garner | Executive Vice President & CFO | SELL | 3.5K | $43.00 | $150K |
| Nov 04, 2025 | Hollie K Foust | General Counsel & Corp Sec | EXERCISE | 4.0K | — | — |
| Oct 31, 2025 | Todd W Garner | Executive Vice President & CFO | EXERCISE | 7.5K | — | — |
| Sep 12, 2025 | Charles Farkas | Director | SELL | 897 | $53.51 | $48K |
| Sep 12, 2025 | Charles Farkas | Director | SELL | 1.1K | $53.53 | $59K |